Currently, patient leaflets list pancreatitis as an uncommon side effect, but regulators are seeking more data to clarify risk
His dedication to innovation and continuing education has solidified his reputation as a leading expert in aesthetic surgery, specializing in breast surgery, body contouring, facial procedures, and non-invasive treatments
The FDAs letters suggest that claims suggesting equivalence to approved drugswhether direct or impliedmay face enforcement action
Current data from ongoing trials indicate that appropriate candidates for retatrutide generally include: Adults aged 18 or older with a BMI of 30 kg/m or greater
For complete disclosure of EGRIFTA WR TM product information, please read the Full Prescribing Information , Patient Information , and Patient Instructions for Use